RMD
Price
$273.44
Change
-$1.94 (-0.70%)
Updated
Aug 29, 04:17 PM (EDT)
Capitalization
40.32B
55 days until earnings call
RSMDF
Price
$16.63
Change
+$0.06 (+0.36%)
Updated
Aug 12 closing price
Capitalization
40.32B
55 days until earnings call
Interact to see
Advertisement

RMD vs RSMDF

Header iconRMD vs RSMDF Comparison
Open Charts RMD vs RSMDFBanner chart's image
ResMed
Price$273.44
Change-$1.94 (-0.70%)
Volume$312
Capitalization40.32B
Resmed
Price$16.63
Change+$0.06 (+0.36%)
Volume$159
Capitalization40.32B
RMD vs RSMDF Comparison Chart in %
Loading...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RMD vs. RSMDF commentary
Aug 29, 2025

To understand the difference between Resmed Inc. (RMD) vs. Resmed Inc. - Chess Depository Interest (RSMDF) it is enough to know the definitions of Chess Depository Interest

Chess Depository Interest - Chess Depositary Interest (CDI) is the instrument developed by a subsidiary of the Australian Securities Exchange (ASX) that gives investors the same beneficial interests in foreign companies and funds as holding these shares and funds directly on their foreign exchange. CDIs investors receive W8-BEN and leverage the Australia-US tax treaty to reduce withholding tax on foreign income.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (RMD: $275.38 vs. RSMDF: $16.57)
Brand notoriety: RMD and RSMDF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RMD: 129% vs. RSMDF: 3%
Market capitalization -- RMD: $40.32B vs. RSMDF: $40.32B
RMD [@Pharmaceuticals: Other] is valued at $40.32B. RSMDF’s [@Pharmaceuticals: Other] market capitalization is $40.32B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RMD’s FA Score shows that 1 FA rating(s) are green whileRSMDF’s FA Score has 1 green FA rating(s).

  • RMD’s FA Score: 1 green, 4 red.
  • RSMDF’s FA Score: 1 green, 4 red.
According to our system of comparison, RMD is a better buy in the long-term than RSMDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RMD’s TA Score shows that 4 TA indicator(s) are bullish while RSMDF’s TA Score has 5 bullish TA indicator(s).

  • RMD’s TA Score: 4 bullish, 4 bearish.
  • RSMDF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RSMDF is a better buy in the short-term than RMD.

Price Growth

RMD (@Pharmaceuticals: Other) experienced а -4.49% price change this week, while RSMDF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.60%. For the same industry, the average monthly price growth was +5.92%, and the average quarterly price growth was +15.12%.

Reported Earning Dates

RMD is expected to report earnings on Oct 23, 2025.

RSMDF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.60% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($40.3B) and RSMDF($40.3B) have the same market capitalization . RMD has higher P/E ratio than RSMDF: RMD (28.96) vs RSMDF (17.49). RMD YTD gains are higher at: 21.201 vs. RSMDF (-27.058). RMD (1.92B) and RSMDF (1.92B) have comparable annual earnings (EBITDA) . RMD (1.21B) and RSMDF (1.21B) have equal amount of cash in the bank . RMD (852M) and RSMDF (852M) have identical debt. RMD (5.15B) and RSMDF (5.15B) have equivalent revenues.
RMDRSMDFRMD / RSMDF
Capitalization40.3B40.3B100%
EBITDA1.92B1.92B100%
Gain YTD21.201-27.058-78%
P/E Ratio28.9617.49166%
Revenue5.15B5.15B100%
Total Cash1.21B1.21B100%
Total Debt852M852M100%
FUNDAMENTALS RATINGS
RMD vs RSMDF: Fundamental Ratings
RMD
RSMDF
OUTLOOK RATING
1..100
5734
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
2190
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (29) in the null industry is in the same range as RMD (38) in the Medical Specialties industry. This means that RSMDF’s stock grew similarly to RMD’s over the last 12 months.

RMD's Profit vs Risk Rating (64) in the Medical Specialties industry is somewhat better than the same rating for RSMDF (100) in the null industry. This means that RMD’s stock grew somewhat faster than RSMDF’s over the last 12 months.

RMD's SMR Rating (100) in the Medical Specialties industry is in the same range as RSMDF (100) in the null industry. This means that RMD’s stock grew similarly to RSMDF’s over the last 12 months.

RMD's Price Growth Rating (21) in the Medical Specialties industry is significantly better than the same rating for RSMDF (90) in the null industry. This means that RMD’s stock grew significantly faster than RSMDF’s over the last 12 months.

RMD's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as RSMDF (100) in the null industry. This means that RMD’s stock grew similarly to RSMDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RMDRSMDF
RSI
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
43%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
40%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 12 days ago
63%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
57%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
34%
View a ticker or compare two or three
Interact to see
Advertisement
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VNAM22.880.27
+1.20%
Global X MSCI Vietnam ETF
SMRI34.040.10
+0.30%
Bushido Capital US Equity ETF
NMAR28.350.07
+0.26%
Innovator Growth-100 Pwr Buffr ETF - Mar
IG20.890.05
+0.24%
Principal Investment Grd Corp Actv ETF
CMF55.81-0.02
-0.04%
iShares California Muni Bond ETF

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-2.33%
SOLV - RMD
46%
Loosely correlated
-0.32%
RVTY - RMD
40%
Loosely correlated
+0.72%
SYK - RMD
39%
Loosely correlated
-0.89%
IDXX - RMD
39%
Loosely correlated
+0.96%
MTD - RMD
38%
Loosely correlated
-0.17%
More

RSMDF and

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
N/A
NAOV - RSMDF
30%
Poorly correlated
-4.30%
RMD - RSMDF
20%
Poorly correlated
-2.33%
PFGTF - RSMDF
19%
Poorly correlated
N/A
POSC - RSMDF
9%
Poorly correlated
-4.71%
SAFLF - RSMDF
9%
Poorly correlated
N/A
More